diabetes

BMJ Open Diabetes Research & Care is an open access diabetes journal committed to publishing high-quality basic and clinical research articles regarding type 1 and type […] The post BMJ Open Diabetes Research & Care appeared first on Pubrica .

Identifying distinctive types of conditions like diabetes is helpful in two ways. It means treatments can be personalized more precisely to individuals, and gives researchers a better idea of how to make those treatments more effective going forward. When it comes to type 1 diabetes, there are two genetic patterns called HLA-DR3 and HLA-DR4 that […]

Identifying distinctive types of conditions like diabetes is helpful in two ways. It means treatments...

New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) shows that, in women that develop type 2 diabetes (T2D), those who had gestational diabetes (GD) when pregnant are developing T2D on average almost 13 years earlier than those who did not.

[Greenstone Biosciences (Business Wire)] Greenstone Biosciences has been awarded a Breakthrough T1D Industry Discovery and Development Partnership grant to develop a T1D-derived islet cell platform aimed at understanding and protecting insulin-producing β cells in people with type 1 diabetes.

For people with type 1 diabetes, eating is closely tied to insulin and blood sugar. That has made doctors cautious about fasting diets, but a new study suggests that carefully limiting food to certain hours of the day may be possible for some adults without increasing major short-term safety risks. The study tested time-restricted eating, […] The post This Fasting Schedule May Help Control Type 1…

Loss of function in the ALDH3B2 gene can convert human pancreatic duct cells into functional β-like cells that in tests secreted insulin in response to glucose, and lowered blood glucose levels when transplanted into diabetic mice. The post Human Pancreatic Duct Cells Show Diabetes Therapy Potential appeared first on GEN - Genetic Engineering and Biotechnology News .

Loss of function in the ALDH3B2 gene can convert human pancreatic duct cells into functional β-like cells that in tests secreted insulin in response to glucose, and lowered blood glucose levels when transplanted into diabetic mice. The post Converted Human Pancreatic Duct Cells Show Diabetes Therapy Potential appeared first on GEN - Genetic Engineering and Biotechnology News .

A recent study by the University of Eastern Finland identified three distinct body mass index (BMI) trajectories among people with type 2 diabetes.

IntroductionChronic vascular exposure to elevated levels of lipoprotein-amyloid-β (Aβ) contributes to blood–brain barrier (BBB) disruption and the pathogenesis of Alzheimer’s disease (AD). Therapeutic agents such as probucol have been shown to reduce circulating lipoprotein-Aβ levels and mitigate neurovascular dysfunction and cognitive decline. Type 2 diabetes (T2D) impairs BBB integrity and is c…

Andelyn Biosciences, a leading contract development and manufacturing organization, announced today that Genprex, Inc. has selected Andelyn to support scale-up manufacturing for its diabetes gene therapy program.

TUESDAY, Sept. 1, 2026 — The number of people living with type 1 diabetes worldwide is projected to jump nearly 30% over the next two decades from 9.4 million today to 12.1 million by 2049.The number of new cases per year is expected to climb too...

Nature Communications, Published online: 31 August 2026; doi:10.1038/s41467-026-77325-2 The authors identify perirenal fat ADRB3 signaling as a regulator of diabetic kidney fibrosis through a Bcat2/BCAA-TNFα pathway, suggesting adipose-kidney crosstalk as a potential therapeutic target.

New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) estimates the number of people living with type 1 diabetes (T1D) worldwide will increase by 29% from 9.4 million in 2025 to 12.1 million in 2049.

Scientists have debated whether the diabetes drug metformin acts primarily in the intestines or the liver. New findings clear up this confusion.

FRIDAY, Aug. 28, 2026 — People with diabetes can now get an early warning when a dangerous complication starts to build in their bodies.The U.S. Food and Drug Administration (FDA) on Tuesday authorized the first wearable sensor that continuously...